Grażyna Zgórka

Dr. Grażyna Zgórka

Department of Pharmacognosy with the Medicinal Plant Garden, Faculty of Pharmacy, Medical University of Lublin, Collegium Universum, 1 Chodźki Street, 20-093 Lublin, Poland
+1
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Grażyna ZgórkaGrażyna Zgórka
Grażyna Zgórka
KGKazimierz Głowniak
Kazimierz Głowniak

1 January 1999 in Journal of Liquid Chromatography & Related Technologies
Verified
Journal Article
Closed access
MEM. Ellnain-Wojtaszek
M. Ellnain-Wojtaszek
Grażyna ZgórkaGrażyna Zgórka
Grażyna Zgórka
In this paper, thin-layer chromatography and high-performance liquid chromatography for the qualitative and quantitative analysis of phenolic acids in Ginkgo biloba L. leaves are described. The amounts of both free and bound phenolic acids were determined within the whole vegetative period. For this purpose, a special extraction procedure, comprising acid and alkaline hydrolyses, was used. The described method allowed us to identify and estimate the concentration levels of eight phenolic acids: protocatechuic, para-hydroxybenzoic, vanillic, caffeic, isovanillic, para-coumaric, ferulic, and sinapic. Depending on the part of the plant vegetation, significant differences in the content of the compounds examined were observed and discussed. The elaborated method could be used in studies on the seasonal distribution of phenolic acids in plant material.


3 May 2019 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
AKAgnieszka Korga-Plewko
Agnieszka Korga-Plewko
MOMarta Ostrowska-Lesko
Marta Ostrowska-Lesko
AJAleksandra Jaromira Józefczyk
Aleksandra Jaromira Józefczyk
MIMagdalena Iwan
Magdalena Iwan
RWRafal Wojcik
Rafal Wojcik
JDJaroslaw Dudka
Jaroslaw Dudka
Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an increasing incidence. Despite the fact that systematic chemotherapy with a doxorubicin provides only marginal improvements in survival of the HCC patients, the doxorubicin is being used in transarterial therapies or combined with the target drug – sorafenib. The aim of the study was to evaluate the effect of natural flavonoids on the cytotoxicity of the doxorubicin against human hepatocellular carcinoma cell line HepG2. The effect of apigenin and its glycosides - cosmosiin, rhoifolin; baicalein and its glycosides – baicalin as well as hesperetin and its glycosides – hesperidin on glycolytic genes expression of HepG2 cell line, morphology and cells’ viability at the presence of doxorubicin have been tested. In an attempt to elucidate the mechanism of observed results, the fluorogenic probe for reactive oxygen species (ROS), the DNA oxidative damage, the lipid peroxidation and the double strand breaks were evaluated. To assess impact on the glycolysis pathway, the mRNA expression for a hexokinase 2 (HK2) and a lactate dehydrogenase A (LDHA) enzymes were measured. The results were analysed statistically with the one-way analysis of variance (ANOVA) and post hoc multiple comparisons. The apigenin and the hesperidin revealed the strongest effect on the toxicity of doxorubicin. Both flavonoids simultaneously changed the expression of the glycolytic pathway genes - HK2 and LDHA, which play a key role in the Warburg effect. Although separate treatment with doxorubicin, apigenin and hesperidin led to a significant oxidative DNA damage and double strand breaks, simultaneous administration of doxorubicin and apigenin or hesperidin abolished these damage with the simultaneous increase in the doxorubicin toxicity. The obtained results indicate the existence of a very effective cytotoxic mechanism in the HepG2 cells of the combined effect of doxorubicin and apigenin (or hesperidin), not related to the oxidative stress. To explain this synergy mechanism, further research is needed, The observed intensification of the cytotoxic effect of doxorubicin by this flavonoids may be a promising direction of the research on the therapy of hepatocellular carcinoma, especially in a chemoembolization.

1 March 2001 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Grażyna ZgórkaGrażyna Zgórka
Grażyna Zgórka
SKSławomir Kawka
Sławomir Kawka